The Deal
Wednesday, November 25, 
6:58 pm

Entries tagged "Advanced Cell Technology Inc"

Stem-cell startups and a lagging IPO market

As noted in a post last week, biotech IPOs are MIA, and venture funding is shaky. The latest quarterly numbers for biopharmaceutical firms -- a tick over $1 billion for the second quarter, according to Dow Jones VentureSource -- is better than the dismal first quarter. But if you carry the first-half total over the full year, the $3.6 billion would be the lowest since 2003, a pretty lousy year in IPOs. ...



Top tags

You have executed a tag search on Dealscape. On the left,you will find a comprehensive list of stories tagged "Advanced Cell Technology Inc." Below are the most-popular tags for Dealscape. On the right of the page you will find a search box to dig deeper into our content.
The Deal Pipeline

Deal Video


Inside The Deal: AlixPartners' Steve Deedy on Black Friday, the holiday season and retail bankruptcies.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

REIT IPO deja vu

By Edward Schneidman, Michael Blair and David Malinger, Mayer Brown

Real estate sponsors that might wish to undertake an IPO will need to consider a wide variety of issues and begin to take action long before the first filing with the SEC.


Industry Insight

Loan-to-buy

By Steven Miller, Standard & Poor's

Paulson's proposal to purchase an equity stake in Yellow Pages publisher Idearc is the second time in recent months an investor group has used its prepetition debt position to execute a bargain price 'exit LBO.'


Industry Insight

Managing your shareholder base

By Bradford P. Weirick and Joelle Khoury, Gibson Dunn

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.



©Copyright 2008, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.